MediPharm Labs Corp. LABS.TO

Company Overview

MediPharm Labs Corp. is a Canadian pharmaceutical company focused on the development, manufacture, and distribution of purified cannabinoid-based products for medical and adult-use markets. The company operates primarily in the cannabis pharmaceutical and wellness industries, with capabilities spanning cannabis extraction, advanced derivative product formulation, and pharmaceutical-quality manufacturing. Its core revenue drivers include the production and sale of cannabis concentrates, cannabinoid oils, softgels, inhalable products, and white-label manufacturing services for licensed brands and healthcare-focused partners.

The company was founded in 2015 and established itself as an early large-scale cannabis extraction specialist in Canada following the legalization of medical and adult-use cannabis. Over time, MediPharm Labs expanded from bulk extraction services into branded medical cannabis products, international pharmaceutical exports, and cannabinoid research initiatives. The company’s positioning has emphasized pharmaceutical manufacturing standards, including Good Manufacturing Practice (GMP) capabilities and regulatory compliance, which differentiates it from operators focused primarily on cultivation.